Impairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytes.
Peginterferon lambda-1a (Lambda), a type III interferon (IFN), acts through a unique receptor complex with limited cellular expression outside the liver which may result in a differentiated tolerability profile compared to peginterferon alfa (alfa). In Phase 2b clinical studies, Lambda administered...
Main Authors: | Jacques Friborg, Petra Ross-Macdonald, Jian Cao, Ryan Willard, Baiqing Lin, Betsy Eggers, Fiona McPhee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4380495?pdf=render |
Similar Items
-
The Role of Type I IFNs in Influenza: Antiviral Superheroes or Immunopathogenic Villains?
by: Wenxin Wu, et al.
Published: (2020-06-01) -
Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs
by: Ivan Zanoni, et al.
Published: (2017-11-01) -
Action of type III IFNs and their roles in immune responses
by: Krzysztof Domagalski, et al.
Published: (2010-10-01) -
SERINC Proteins Potentiate Antiviral Type I IFN Induction and Proinflammatory Signaling Pathways
by: Cong Zeng, et al.
Published: (2020-06-01) -
The role of STAT3 inhibitors in Type I IFN-mediated signaling and antiviral responses
by: Chien-Hui Liao, et al.
Published: (2012)